Katherine A Hoadley

Bio: Katherine A Hoadley is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Induced pluripotent stem cell & Epigenome. The author has an hindex of 5, co-authored 5 publications receiving 2750 citations.

Integrative analysis of 111 reference human epigenomes

Abstract: The reference human genome sequence set the stage for studies of genetic variation and its association with human disease, but epigenomic studies lack a similar reference. To address this need, the NIH Roadmap Epigenomics Consortium generated the largest collection so far of human epigenomes for primary cells and tissues. Here we describe the integrative analysis of 111 reference human epigenomes generated as part of the programme, profiled for histone modification patterns, DNA accessibility, DNA methylation and RNA expression. We establish global maps of regulatory elements, define regulatory modules of coordinated activity, and their likely activators and repressors. We show that disease- and trait-associated genetic variants are enriched in tissue-specific epigenomic marks, revealing biologically relevant cell types for diverse human traits, and providing a resource for interpreting the molecular basis of human disease. Our results demonstrate the central role of epigenomic information for understanding gene regulation, cellular differentiation and human disease.

Hallmarks of Cancer: New Dimensions

Abstract: The hallmarks of cancer conceptualization is a heuristic tool for distilling the vast complexity of cancer phenotypes and genotypes into a provisional set of underlying principles. As knowledge of cancer mechanisms has progressed, other facets of the disease have emerged as potential refinements. Herein, the prospect is raised that phenotypic plasticity and disrupted differentiation is a discrete hallmark capability, and that nonmutational epigenetic reprogramming and polymorphic microbiomes both constitute distinctive enabling characteristics that facilitate the acquisition of hallmark capabilities. Additionally, senescent cells, of varying origins, may be added to the roster of functionally important cell types in the tumor microenvironment. SIGNIFICANCE: Cancer is daunting in the breadth and scope of its diversity, spanning genetics, cell and tissue biology, pathology, and response to therapy. Ever more powerful experimental and computational tools and technologies are providing an avalanche of "big data" about the myriad manifestations of the diseases that cancer encompasses. The integrative concept embodied in the hallmarks of cancer is helping to distill this complexity into an increasingly logical science, and the provisional new dimensions presented in this perspective may add value to that endeavor, to more fully understand mechanisms of cancer development and malignant progression, and apply that knowledge to cancer medicine.

Visualizing and interpreting cancer genomics data via the Xena platform.

Abstract: To the Editor — There is a great need for easy-to-use cancer genomics visualization tools for both large public data resources such as TCGA (The Cancer Genome Atlas)1 and the GDC (Genomic Data Commons)2, as well as smaller-scale datasets generated by individual labs. Commonly used interactive visualization tools are either web-based portals or desktop applications. Data portals have a dedicated back end and are a powerful means of viewing centrally hosted resource datasets (for example, Xena’s predecessor, the University of California, Santa Cruz (UCSC) Cancer Browser (currently retired3), cBioPortal4, ICGC (International Cancer Genomics Consortium) Data Portal5, GDC Data Portal2). However, researchers wishing to use a data portal to explore their own data have to either redeploy the entire platform, a difficult task even for bioinformaticians, or upload private data to a server outside the user’s control, a non-starter for protected patient data, such as germline variants (for example, MAGI (Mutation Annotation and Genome Interpretation6), WebMeV7 or Ordino8). Desktop tools can view a user’s own data securely (for example, Integrated Genomics Viewer (IGV)9, Gitools10), but lack well-maintained, prebuilt files for the ever-evolving and expanding public data resources. This dichotomy between data portals and desktop tools highlights the challenge of using a single platform for both large public data and smaller-scale datasets generated by individual labs. Complicating this dichotomy is the expanding amount, and complexity, of cancer genomics data resulting from numerous technological advances, including lower-cost high-throughput sequencing and single-cell-based technologies. Cancer genomics datasets are now being generated using new assays, such as whole-genome sequencing11, DNA methylation whole-genome bisulfite sequencing12 and ATAC-seq (Assay for Transposase-Accessible Chromatin using sequencing13). Visualizing and exploring these diverse data modalities is important but challenging, especially as many tools have traditionally specialized in only one or perhaps a few data types. And although these complex datasets generate insights individually, integration with other omics datasets is crucial to help researchers discover and validate findings. UCSC Xena was developed as a high-performance visualization and analysis tool for both large public repositories and private datasets. It was built to scale with the current and future data growth and complexity. Xena’s privacy-aware architecture enables cancer researchers of all computational backgrounds to explore large, diverse datasets. Researchers use the same system to securely explore their own data, together or separately from the public data, all the while keeping private data secure. The system easily supports many tens of thousands of samples and has been tested with up to a million cells. The simple and flexible architecture supports a variety of common and uncommon data types. Xena’s Visual Spreadsheet visualization integrates gene-centric and genomic-coordinate-centric views across multiple data modalities, providing a deep, comprehensive view of genomic events within a cohort of tumors. UCSC Xena (http://xena.ucsc.edu) has two components: the front end Xena Browser and the back end Xena Hubs (Fig. 1). The web-based Xena Browser empowers biologists to explore data across multiple Xena Hubs with a variety of visualizations and analyses. The back end Xena Hubs host genomics data from laptops, public servers, behind a firewall, or in the cloud, and can be public or private (Supplementary Fig. 1). The Xena Browser receives data simultaneously from multiple Xena Hubs and integrates them into a single coherent visualization within the browser. A private Xena Hub is a hub installed on a user’s own computer (Supplementary Fig. 2). It is configured to only respond to requests from the computer’s localhost network interface (that is, http://127.0.0.1). This ensures that the hub only communicates with the computer on which the hub is installed. A public hub is configured to respond to requests from external computers. There are two types of public Xena Hubs (Supplementary Fig. 2). The first type is an open-public hub, which is a public hub accessible by everyone. While we host several open-public hubs (Supplementary Table 1), users can also set up their own as a way to share data. An example of one is the Treehouse Hub set up by the Childhood Cancer Initiative to share pediatric cancer RNA-seq gene expression data (Supplementary Note). The second type W eb s er ve r